

Cover Story
By Claire Dietz and Matthew Bin Han Ong
The Cancer Prevention and Research Institute of Texas—the second largest publicly-funded granting organization for cancer after NIH—may receive $3 billion more to stay open past its current sunset date in 2023.
Conversation with The Cancer Letter
By Claire Dietz and Matthew Bin Han Ong
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- How George Tidmarsh crossed the FDA-industry Rubicon
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA















